Federal Register / Vol. 88, No. 244 / Thursday, December 21, 2023 / Notices 88417 

If additional information is required 

contact: Darwin Arceo, Department 

Clearance Officer, United States 

Department of Justice, Justice 

Management Division, Policy and 

Planning Staff, Two Constitution 

Square, 145 N Street NE, 4W–218, 

Washington, DC. 

Dated: December 18, 2023. 

Darwin Arceo, 

Department Clearance Officer for PRA, U.S. 

Department of Justice. 

[FR Doc. 2023–28107 Filed 12–20–23; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Notice of Extension of Comment 

Period on Proposed Consent Decrees 

Under the Comprehensive 

Environmental Response, 

Compensation, and Liability Act 

(CERCLA), the Clean Water Act (CWA), 

and the Oil Pollution Act (OPA) 

On November 1, 2023, the Department 

of Justice lodged two proposed consent 

decrees with the United States District 

Court for the District of Oregon in the 

lawsuit entitled United States of 

America et al. v. ACF Industries LLC, et 

al., Civil Action No. 3:23–cv–1603 (D. 

Or.). Notice of this settlement was 

published in the Federal Register at 88 

FR 78063 (Nov. 14, 2023), which 

announced a 45-day comment period. 

Based on the date of that Federal 

Register notice, the comment period 

was scheduled to end on December 29, 

2023. 

On December 11, 2023, Plaintiffs in 

the above-captioned settlement received 

a request to extend the comment period 

by an additional forty-five (45) days. 

After considering this request, Plaintiffs 

have decided to extend the original 

comment period by an additional thirty 

(30) days. This extension provides a 

total comment period of seventy-five 

(75) days, through and including 

January 28, 2024. 

Comments on the proposed Consent 

Decrees should be addressed to the 

Assistant Attorney General, 

Environment and Natural Resources 

Division, and should refer to United 

States of America et al. v. ACF 

Industries LLC, et al., D.J. Ref. No. 90– 

11–2–06787/2. 

Comments may be submitted either by 

email or by mail: 

To submit 

comments: Send them to: 

By email ....... pubcomment-ees.enrd@

usdoj.gov. 

To submit 

comments: Send them to: 

By mail ......... Assistant Attorney General, 

U.S. DOJ—ENRD, P.O. 

Box 7611, Washington, DC 

20044–7611. 

During the public comment period, 

the Consent Decrees may be examined 

and downloaded at this Justice 

Department website: https://

www.justice.gov/enrd/consent-decree/ 

us-et-al-v-acf-industries-llc-et-al. Please 

note that this website contains the 

corrected version of the cash-out 

consent decree but not the version 

originally lodged with the court. The 

corrected version of the cash-out 

consent decree adds a legal entity for 

one of the settling defendants that 

inadvertently was omitted but does not 

change the scope of the operations 

covered by the consent decree or the 

amounts to be paid under the consent 

decree. Please refer to the corrected 

version of the cash-out consent decree 

when submitting comments. We will 

provide a paper copy of the Consent 

Decrees upon written request and 

payment of reproduction costs. Please 

mail your request and payment to: 

Consent Decree Library, U.S. DOJ— 

ENRD, P.O. Box 7611, Washington, DC 

20044–7611. 

Please enclose a check or money order 

for $45.25 (without attachments) or 

$631.25 (with attachments) (25 cents per 

page reproduction cost) payable to the 

United States Treasury. 

Kathryn C. Macdonald, 

Assistant Section Chief, Environmental 

Enforcement Section, Environment and 

Natural Resources Division. 

[FR Doc. 2023–28017 Filed 12–20–23; 8:45 am] 

BILLING CODE 4410–15–P 

DEPARTMENT OF JUSTICE 

[OMB Number 1117–0021] 

Agency Information Collection 

Activities; Proposed eCollection 

eComments Requested; Extension of a 

Previously Approved Collection; 

Dispensing Records of Individual 

Practitioners 

AGENCY: Drug Enforcement 

Administration, Department of Justice. 

ACTION: 60-Day notice. 

SUMMARY: The Drug Enforcement 

Administration, Department of Justice 

(DOJ), will be submitting the following 

information collection request to the 

Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. 

DATES: Comments are encouraged and 

will be accepted for 60 days until 

February 20, 2024. 

FOR FURTHER INFORMATION CONTACT: If 

you have additional comments 

especially on the estimated public 

burden or associated response time, 

suggestions, or need a copy of the 

proposed information collection 

instrument with instructions or 

additional information, please contact 

Scott A Brinks, Regulatory Drafting and 

Policy Support Section, Drug 

Enforcement Administration; Mailing 

Address: 8701 Morrissette Drive, 

Springfield, Virginia 22152; Telephone: 

(571) 362–3261; Email: DPW@dea.gov. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the Bureau of Justice 

Statistics, including whether the 

information will have practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Evaluate whether and if so how the 

quality, utility, and clarity of the 

information to be collected can be 

enhanced; and 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Abstract: Pursuant to 21 U.S.C. 827(c), 

practitioners who regularly dispense or 

administer controlled substances to 

patients and charge them for the 

substances and those practitioners who 

administer controlled substances in the 

course of maintenance or detoxification 

treatment shall keep records of such 

activities, and accordingly must comply 

with the regulations on recordkeeping. 

Overview of This Information 

Collection 

1. Type of Information Collection: 

Extension of a previously approved 

collection. 


khammond on DSKJM1Z7X2PROD with NOTICES